Efficacy and Safety of Remdesivir in Hospitalized Pediatric COVID-19: A Retrospective Case-Controlled Study.

Ahmed KhalilAsmaa MohamedManasik HassanSamar MagboulHossamaldein AliAhmed Salah ElmasoudiKhaled EllithyMohammad QusadAbdulla AlhothiEman Al MaslamaniMohammed Al AmriAshraf Soliman

Published in: Therapeutics and clinical risk management (2023)

The outcomes indicate that Remdesivir may represent a safe and therapeutic choice for children with coronavirus disease 2019 (COVID-19).

Keyphrases

coronavirus disease
respiratory syndrome coronavirus
sars cov
young adults
type diabetes
decision making